Basel Medical Group Ltd (BMGL) Cash Flow Statement
Where BMGL’s cash came from and went, FY2025
June 30, 2025 · Singapore dollars- Cash from operations
- −S$4.3M −273.1% vs FY2024
- Capital expenditures
- S$54,760 0.5% of revenue
- Free cash flow
- −S$4.4M −38.9% margin
- Returned to shareholders
- —
- Change in cash
- S$1.0M cash at year-end S$3.0M
Drawn to scale: where the cash came from and how it was used. Hover for values.
BMGL operating cash flow, capex and free cash flow
BMGL cash flow trends, FY2022–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | S$2.8MFY2022 | −S$4.3MFY2025 | — | |
| Capital expenditures | S$88,495FY2022 | S$54,760FY2025 | −14.8%/yr | |
| Free cash flow | S$2.7MFY2022 | −S$4.4MFY2025 | — | |
| Free cash flow margin | 25.4%FY2022 | −38.9%FY2025 | −64.2 pts | |
| Operating cash flow / net income | 1.17FY2022 | 1.04FY2024 | −0.13 | |
| Capex / revenue | 0.8%FY2022 | 0.5%FY2025 | −0.3 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BMGL cash flow by activity
BMGL net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
BMGL cash flow statement in Singapore dollars
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Operating activities | ||||
| Net income | −S$12.5M | S$2.4M | S$2.1M | S$2.4M |
| Depreciation & amortization | S$1.2M | S$528,728 | S$557,128 | S$575,919 |
| Change in working capital | −S$3.3M | −S$4,819 | S$286,801 | S$81,367 |
| Other non-cash items | S$10.2M | −S$419,185 | −S$375,507 | −S$251,263 |
| Cash from operating activities | −S$4.3M | S$2.5M | S$2.6M | S$2.8M |
| Investing activities | ||||
| Capital expenditures | −S$54,760 | −S$7,920 | −S$6,162 | −S$88,495 |
| Investments (net) | −S$11.0M | −S$7,920 | −S$6,162 | −S$88,495 |
| Acquisitions & other investing | S$54,760 | S$7,920 | S$6,162 | S$88,495 |
| Cash from investing activities | −S$11.0M | −S$7,920 | −S$6,162 | −S$88,495 |
| Financing activities | ||||
| Net borrowing (repayment) | −S$5.2M | −S$2.9M | −S$2.9M | −S$2.1M |
| Shares issued | S$9.8M | S$0 | S$0 | S$0 |
| Other financing | S$12.3M | S$1.2M | S$325 | −S$10.9M |
| Cash from financing activities | S$16.9M | −S$1.8M | −S$2.9M | −S$12.9M |
| Summary | ||||
| Net change in cash | S$1.0M | S$733,605 | −S$346,235 | −S$10.2M |
| Cash at end of period | S$3.0M | S$2.0M | S$1.2M | S$1.6M |
| Free cash flow | −S$4.4M | S$2.5M | S$2.6M | S$2.7M |
| Free cash flow margin | −38.9% | 24.9% | 26.7% | 25.4% |
| Capex / revenue | 0.5% | 0.1% | 0.1% | 0.8% |
| Operating cash flow / net income | — | 1.04 | 1.22 | 1.17 |
| Mar '26 | Sep '25 | |
|---|---|---|
| Operating activities | ||
| Net income | S$268,443 | −S$9.9M |
| Depreciation & amortization | S$2.1M | S$799,142 |
| Change in working capital | −S$4.0M | −S$1.3M |
| Other non-cash items | S$45,335 | S$10.2M |
| Cash from operating activities | −S$1.6M | −S$302,732 |
| Investing activities | ||
| Capital expenditures | −S$124,509 | −S$518,802 |
| Acquisitions & other investing | S$349,393 | −S$10.0M |
| Cash from investing activities | S$224,884 | −S$10.5M |
| Financing activities | ||
| Shares issued | S$0 | S$0 |
| Other financing | −S$715,256 | S$7.0M |
| Cash from financing activities | −S$715,256 | S$7.0M |
| Summary | ||
| Net change in cash | −S$1.7M | −S$3.9M |
| Cash at end of period | S$1.3M | S$3.0M |
| Free cash flow | −S$1.8M | −S$821,534 |
| Free cash flow margin | −21.3% | −13.6% |
| Capex / revenue | 1.5% | 8.6% |
| Operating cash flow / net income | −6.07 | — |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in Singapore dollars as reported; data from EODHD.
BMGL cash generation
In fiscal 2025 (ended June 30, 2025), Basel Medical generated -S$4.3 million of cash from operations (down 273.1%) and spent S$0.1 million on capital expenditures, leaving free cash flow of -S$4.4 million, −38.9% of revenue. Cash and equivalents rose by S$1.0 million over the year.
Related: BMGL income statement, BMGL balance sheet. See the BMGL stock overview for the latest quote and news.
BMGL cash flow FAQ
What is Basel Medical's free cash flow?
Basel Medical's free cash flow was -S$4.4 million in fiscal 2025: -S$4.3 million of operating cash flow minus S$0.1 million of capital expenditures It was S$2.5 million a year earlier..
How much cash does Basel Medical generate from operations?
Basel Medical generated -S$4.3 million of cash from operating activities in fiscal 2025.
How much does Basel Medical spend on capital expenditures?
Basel Medical spent S$0.1 million on capital expenditures in fiscal 2025, 0.5% of revenue, compared with S$0.0 million the year before.